Can I skip a dose without messing up my cycle?
Yes — occasional missed doses don't ruin most peptide cycles. Don't double up to catch up. The impact varies by peptide half-life and dosing frequency.
Updated May 8, 2026 · 6 min read
Yes — occasional missed doses are fine for most peptides. The cycle isn't ruined by one or two skipped injections. Don't double up the next day to "catch up" — that just exposes you to a higher peak dose with no benefit. The impact of a missed dose depends on the peptide's half-life and how often it's normally dosed. A missed daily dose is barely noticeable. A missed weekly dose of a long-acting compound is also barely noticeable. The pattern that matters is whether skipping becomes habitual.
The honest framing: cycle protocols assume reasonable adherence, not perfect adherence. Missing 5-10% of doses across a cycle won't change the outcome meaningfully for any peptide on this site.
By peptide and frequency
Different peptides handle missed doses differently:
| Peptide | Normal cadence | Missing one dose |
|---|---|---|
| BPC-157 | Daily SubQ | No big deal — resume normal dosing the next day |
| TB-500 | Twice weekly loading, then weekly/biweekly | Negligible — long half-life smooths it out |
| Ipamorelin | 1-3x daily | Skipping the pre-bed dose loses one GH pulse — minor |
| CJC-1295 (no DAC) | Paired with Ipa | Same as Ipa — minor |
| CJC-1295 with DAC | Weekly | Negligible — long half-life means you have residual peptide for days |
| Sermorelin | Pre-bed daily | Negligible for one night |
| MK-677 | Daily oral | Negligible — half-life is hours but the receptor activity smooths over a day |
| IGF-1 LR3 | Daily | Modest impact — short cycle means each dose carries more weight |
| MOTS-c | 2-3x weekly | Negligible |
| GHK-Cu | Daily topical or 2-3x weekly injection | Negligible |
| Tesamorelin | Daily | Negligible for one day |
The "don't double up" rule
The temptation to take twice the next dose to make up for a missed one is wrong for every peptide on this list. The reasoning:
| Peptide class | Why doubling is wrong |
|---|---|
| BPC-157, TB-500 | More peptide doesn't accelerate tissue healing past the dose-response curve |
| GH secretagogues | Doubling stacks side effects (water retention, glucose drift) without doubling effect |
| IGF-1 LR3 | Doubling the dose materially increases hypoglycemia risk |
| MK-677 | Doubling extends the post-dose ghrelin effect; appetite, water retention, sleep effects all amplified |
The right move is always: skip the missed dose, resume normal dosing on schedule.
How many missed doses before it matters?
Rough guidance — these aren't bright lines:
| Pattern | Impact |
|---|---|
| 1 missed dose in a 4-6 week cycle | None noticeable |
| 2-3 missed doses scattered across a cycle | Negligible for most peptides |
| 5%+ of total doses missed | Probably a slight reduction in effect; not enough to abandon the cycle |
| 10%+ of total doses missed | Approaching the threshold where you should ask whether the protocol is fitting your life |
| 1-2 missed days in a row | For daily peptides, 1-2 day gaps are fine; for IGF-1 LR3 specifically, try harder to maintain the pattern |
| 1+ week gap | Not really a missed dose — you've taken a break. Treat as cycle interruption. |
For longer gaps, see can I restart peptides if I stopped early.
The pre-bed GH-secretagogue case
The most common "should I take it" decision is the pre-bed Ipa+CJC dose when you forgot earlier in the day. The framework:
- If you remember within 1 hour of intended dose time: take it.
- If you're already going to bed: skip. The dose timing matters because GH secretagogues are designed to amplify a sleep-onset GH pulse. A late-night dose past sleep onset doesn't do what the protocol intended.
- Don't take it earlier in the next morning to compensate. The morning dose hits a different physiological window than the pre-bed dose.
Lost one GH pulse over a 12-week cycle is not a meaningful loss.
The IGF-1 LR3 case
IGF-1 LR3 is the one peptide where missed doses matter slightly more, for two reasons:
- The cycle is short (4-6 weeks). Each dose is a larger fraction of the total cycle exposure.
- The peptide has a measurable acute effect (hypoglycemia risk in the post-injection window). Skipping isn't dangerous, but the protocol is built around consistent daily exposure.
Even with IGF-1 LR3, a single missed dose isn't a problem. Don't double up. Resume on schedule.
The CJC-1295 DAC case
This is the cleanest "missed dose, no problem" peptide on the list. CJC-1295 with DAC has roughly a 7-day half-life. Missing the weekly injection by a day or two has almost no detectable effect — there's still a meaningful concentration of peptide in your system from the previous dose.
The standard advice: if you forgot Monday's injection and remember Tuesday, take it Tuesday and shift the schedule, or take it Tuesday and return to Monday the following week. Either is fine. Don't take a second dose later that week to "catch up to schedule."
When skipping signals a different problem
The honest version: most missed doses aren't accidents. They're early signals about whether the protocol fits your life.
| Pattern | What it might mean |
|---|---|
| Forgetting once a week | Reasonable — life happens |
| Forgetting consistently on certain days (e.g., weekends, travel days) | Protocol-life mismatch; consider adjusting cadence |
| Avoiding the injection because of the injection itself | Subcutaneous fatigue, vendor issue, or psychological resistance — worth examining |
| Skipping because side effects are piling up | This isn't "missing a dose" — it's an unannounced stop. See when should I stop a peptide cycle early. |
| Running out of vials before the cycle ends | Inventory issue; plan ahead next time |
If the missed-dose pattern is structural rather than incidental, the question isn't really "can I skip a dose." It's "is this the right protocol for my life."
Tracking what you actually took
The simplest correction to dose-skipping is writing it down. A short log:
- Date and time of injection
- Dose
- Site (rotate sites)
- Vial batch
- Anything notable (skip reason, side effect, etc.)
Cycles look different in retrospect when you have actual data versus memory. "I think I was pretty consistent" usually means worse than 90% adherence; written logs typically show worse compliance than people remember.
For more on dosing precision, see common dosing errors.